TrademarkDir
ARODIGE
LIVE

Serial Number

79252813

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 12, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ARODIGE Trademark

Serial Number: 79252813 • Registration: 5823945

ARODIGE is a trademark filed by NOVARTIS AG on December 12, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 12, 2018

Registration Date

August 6, 2019

Published for Opposition

May 21, 2019

Cancellation Date

June 29, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 22, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 22, 2026 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 6, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 13, 2019 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 25, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 25, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 6, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2019 CNSA
REFUSAL PROCESSED BY IB
Apr 12, 2019 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2019 CRFA
ASSIGNED TO LIE
Apr 5, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2019 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 5, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 25, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 21, 2019 SDRC

Related Trademarks

More from this Owner

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA

CALIHE

CALIHE